Healthcare reform in US remains on hold
This article was originally published in Clinica
Executive Summary
First, there was furious lobbying, and then nothing. Peter Rixon reports on what happened to the much-talked about healthcare reform in the US, what options are left open for Democrats who are so eager to pass reform and the industry that is very keen to ensure it gets a good deal
You may also be interested in...
US: The sun shines in on industry-doctor relationships
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Global regulators/industry to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Global regulators and industry execs to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.